This article is reprinted from the Utrecht 3Rs newsletter, with the message of Jan Langermans, Professor ‘Welfare of Laboratory Animals’ at Utrecht University and also deputy director of Biomedical Primate Research Centre, Netherlands, on welfare improvement of animals used in research.
More attention to the welfare improvement of laboratory animals. That is the message prof. dr. Jan Langermans wants to propagate. He was recently appointed professor ‘Welfare of Laboratory Animals’ at the Faculty of Veterinary Medicine at Utrecht University. He will focus on the welfare improvement of larger animals used for scientific purposes.
“In those fields of research where we cannot move forward without laboratory animals, we have to invest in the highest possible welfare standards” says Langermans. “This is an essential part of responsible use of animals for research.” He emphasizes that with refinement, he does not only mean the reduction of pain and discomfort, but also the introduction of positive aspects that contribute to a positive welfare state. For example, simple improvements in food or cage enrichment and creating positive associations with the experimental procedures by means of training can make a huge difference in the quality of life of these animals. Three themes on which he wants to focus are the training of laboratory animals, the introduction of enrichment under experimental conditions and the use of innovative techniques to improve welfare and reduce the number of animals needed for research.
Training both animals and researchers
“An important question that people who work with laboratory animals must continuously ask themselves is: how can we improve the circumstances for these animals?” says Langermans. Continue reading →
The European Animal Research Association (EARA) has submitted a guidance document on Non-Technical Summaries (NTS) to the EU Commission on how NTS can be made more understandable for the ordinary reader.
The details were presented by Javier Guillén, (pictured below) a member of the EARA working group that produced the guidance document, at the 14th FELASA Congress, held in Prague, Czech Republic, last week.
Javier told the Congress that
as part of its strategy to improve openness and transparency on the use of
animals in research in Europe, EARA has been working closely with the EU to
help improve the information provided to the general public.
It is understood that the Commission will produce additional guidance on NTS for Member States using some of the EARA guidance document findings.
Every research project application, that intends to use animals, is required to include a publicly available NTS which includes a simple explanation of the project’s objectives, predicted harms, benefits and number and types of animals used. It must also demonstrate compliance with the 3Rs (replacement, reduction and refinement). Continue reading →
On the eve of Biomedical Research Awaerness Day (BRAD 18 April), EARA looks back at some of the important medical advances over the last year that have involved research using animals.
Among the breakthroughs reported,
that benefit both humans and animals, are:
Research using mice led to many new breakthroughs, such as multiple sclerosisresearch, at the University of Cambridge and to fight chronic pain using synthetic Botox at University College London, UK.
In surgical research on sheep at Lund University, Sweden, freeze-dried valves – later rehydrated for transplantation – were used in animal heart surgery for first time.
A team from the Spanish National Cancer Research Centre (CNIO), Madrid, Spain, succeeded in curing pulmonary fibrosis disease in mice using a gene therapy.
In Belgium, researchers at EARA members VIB, KU Leuven and UZ Leuven used mice to develop new antibacterial drugs.
Building on a technique developed in rats, Swiss researchers at the Swiss Federal Institute of Technology, in Lausanne, have announced that stimulating a person’s spinal cord can restore voluntary movement in some paralysed patients (see picture).
Scientists are also developing new biomedical treatments and
techniques that replace, refine or reduce (3Rs) the use of animals in research.
A team from the University of Oxford, UK, and EARA member Janssen Pharmaceutica, Belgium, won the International 3Rs Prize using a computer model that predicts accurately the risk of drug-induced heart arrhythmias in humans.
Animal research is integral to ongoing research in areas such as spinal cord repair, stem cell treatments (Parkinson’s and Alzheimer’s), gene therapy (muscular dystrophy, diabetes) and molecularly targeted cancer medicines. Historically, animal research has also led to new diagnostic tests for early treatment (cancer, heart disease); and effective treatments for serious illnesses (diabetes, leukemia, HIV/AIDS, cardiovascular disease).
The same research often helps humans and animals (treatments for arthritis, neurological disorders, organ transplants, cancer therapies) and contributes to farm animal welfare and techniques to save endangered species.
EARA Executive Director, Kirk Leech, said: “Without the use of animals the pace of advances in biomedical research would be dramatically slower.
“Finding alternative methods to animal research, such as computer models and cell cultures are extremely important, but animal testing remains the safest and most effective way to produce drugs and treatments for us all.”
In a piece first published in the Belgian news magazine Knack (in Dutch), Prof. Damya Laoui, from the Flemish Institute for Biotechnology (VIB, an EARA member), in Belgium, together with Dr. Liesbeth Aerts and Dr. Jeroen Aerts from Infopunt Proefdieronderzoek (IPPO, also an EARA member), explain that researchers don’t take the use of animals in biomedical research lightly.
Many people are critical of animal testing, and
from an emotional point of view this is very understandable. Animals are living
beings. They have basic emotions and they also experience physical pain. As
researchers, we are not blind or insensitive to animal suffering, but neither
can we ignore the pain of almost 10 million people who die of cancer worldwide
In 2018, some 70,000 Belgians received a new
cancer diagnosis. Fortunately, their prognosis is in many cases a lot better
than for people who received the same diagnosis 10 or 20 years ago. Thanks to
advances in biomedical research – including through animal testing – the
treatment options for cancer are rapidly expanding. Nevertheless, the number of
cancer cases continues to increase as well, and the disease continues to take
To the people who claim that we can face this
challenge without animal research, we would say: please walk the talk. From our
hands-on experience as biomedical researchers, we would like to argue for greater
nuance in the debate against animal testing. Let’s bust some often heard myths:
Myth One: Animal testing is no longer necessary because we can get the
same results through computer simulations
At a roundtable discussion on the use of animals in scientific research there is overwhelming agreement that Europe has appropriate and detailed legislation regulating the use of animals in scientific research, that adapts to and encourages scientific progress.
Conclusions also show that successful implementation of the Directive is a shared responsibility. The round table identified opportunities to join forces and work together, as the Directive 2010/63/EU cannot be successfully implemented by organisations or individuals working in isolation.
At the meeting in Brussels, representatives from the diverse sectors within the biomedical community (academia, industry, research organisations, medical charities, etc.) and policy-makers discuss the recommendations of the European Commission review report of the Directive 2010/63/EU on the protection of animals used for scientific purposes.
The objective of the roundtable was to inform policy discussion in EU institutions and to identify recommendations for the users’ community on this basis. Topics under discussion were: the implementation of the Directive; improving openness and transparency; ideas for further areas to be tackled. Continue reading →
EARA has responded to a call by the Dutch Science Minister for the Biomedical Primate Research Centre (BPRC), in the Netherlands, an EARA member, to draw up a proposal, by the beginning of next year, to reduce the number of experiments with no-human primates (NHP) by up to 40%.
Ahead of a debate, which took place in the Netherlands House of Representatives earlier this month, EARA wrote to Ingrid van Engelshoven, Minister of Education, Culture and Science and Carola Schouten, Minister of Agriculture, Nature and Food Quality, urging them not to set an artificial limit on the number of NHP used in research.
The letter, written by EARA, said that any reduction was “highly likely to severely limit the progress that can be made in both fundamental research and the development of innovative medicines and treatments for life-threatening diseases and infectious disease control”.
Currently the main areas of primate study are infectious diseases, neuroscience and fertility and foetal research. Primates are an important model for the development of vaccines and treatments for HIV/AIDS, Ebola, Zika and malaria and for investigations into treatments for conditions ranging from Alzheimer’s disease to Schizophrenia. They are also used in safety testing for new medicines and vaccines. Continue reading →
The European scientific community supports the view of the EU Commission, that the Directive on the protection of animals used in biomedical research is bringing significant benefits in animal welfare and a sound foundation for future best practice in the sector.
The European Animal Research Association (EARA), which represents more than 60 organisations across Europe in the biomedical research sector, has welcomed the Commission report, published today. The report reviews the requirements of Directive 2010/63/EU – all uses of live animals for research or education and testing must be carried out in compliance with the Directive.
In particular, the EU recognised that measures to improve transparency to the general public on the performance of research establishments in the areas of animal use and welfare are starting to have an effect. Requirements to publish non-technical summaries of the objectives and benefits of research projects, as well as annual statistical data, are also seen to have greatly improved openness in Member States. Continue reading →
The European Directive 2010/63 that protects animals required for scientific purposes was enforced in Member states in 2012. The Directive introduced the 3R principles of replacement, reduction and refinement of animal procedures into regulation. The scientific community has recognised the Directive as the world’s most progressive and stringent framework seeking to ensure high animal welfare standards while encouraging the development of alternative methods. As a result of this new legislation, there has been a growing interest in the development and implementation of alternative methods. One initiative pursuing this goal is the European Partnership for Alternative Approaches to Animal Testing (EPAA). Continue reading →